Bio Rad Laboratories, Inc. (BIO) jumped higher on better than expected Q3 results from late November.

Company Description

Bio-Rad Laboratories Inc., together with its subsidiaries, manufactures products and systems for the life sciences and healthcare industry worldwide. The company was founded in 1952 and has a market cap of $2.65 billion.

Shares of BIO jumped higher and hit a new 52-week high after the company reported better than expected third-quarter results on Nov 24.

Third-Quarter Results

Sales were up 4.4% from last year to $461 million. Earnings also came in strong at $1.38, 38 cents ahead of the Zacks Consensus Estimate. The company has beat in each of the last 4 quarters by an average of 28 cents or 29%.

Bio Rad noted that its largest business segment, Clinical Diagnostics, was up 9.3% to $308 million. Gross margin expanded 2% to 56% while the company’s cash and equiviliants increased $349 million to $554 million.

Estimates Up

The good quarter sent estimates higher, with the current year adding 40 cents and moving to $4.98. The next-year estimate added 57 cents, clocking in at $5.43, a solid 9% growth projection.

Valuation

Based on the current-year estimate, shares of BIO trade with a P/E multiple of 19X, a small premium to the overall market.

The Chart

Bio Rad jumped higher on word of the good quarter but have since traded mostly sideways. Take a look below.

Michael Vodicka is the Momentum Stock Strategist for Zacks.com. He is also the Editor in charge of the market-beating Zacks Surprise Trader Service. Zacks Investment Research

1. (CLB) Core Laboratories N.V. Reports Better-Than-Expected ResultsOilfield services provider Core Laboratories N.V. (CLB) has reported slightly better-than-expected third-quarter results, driven by...
2. (BIO) Bio-Rad Laboratories, Inc. – Earnings Came in StrongBio-Rad Laboratories, Inc. (BIO) recently hit a new 52-week high as the global economy recovers...
3. Bio-Rad Laboratories – Beat in Each of the Last 3 Quarters by an Average of 25%Bio-Rad Laboratories, Inc. (BIO) recently hit a new 52-week high as the global economy recovers...
4. (RHT) Red Hat’s Q2 Results Beat ForecastsThe leader in open source software solutions, Red Hat, Inc.’s (RHT) second-quarter results beat consensus...
5. (EMC) EMC’s Results Above Expectations – fourth quarter is expected to be the strongest quarter of the yearEMC Corp.’s (EMC) second quarter results were better than analysts’ expectations. Although results were down...
6. (BRLI) Bio-Reference Laboratories – This was the second consecutive quarter that the company has surprised and beat estimatesBio-Reference Laboratories, Inc. (BRLI) share price has been rallying since the company reported excellent fourth-quarter...

Search Posts by Tag: BIO | Bio-Rad Laboratories Inc | Scientific & Technical Instruments | Technology

RSS Feeds by Tag: BIO | Bio-Rad Laboratories Inc | Scientific & Technical Instruments | Technology |

Other Posts by: vitalstocks | RSS Feed for this author